Methylene Blue-Assisted Lymph Node Dissection in Gastric Cancer Specimens

Methylene Blue-Assisted Lymph Node Dissection in Gastric Cancer Specimens - Methylene Blue-Assisted Lymph Node Dissection in Gastric Cancer Specimens

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008624

Enrollment

Registered

2012-08-05

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (i) Histologically proven adenocarcinoma of the stomach. (ii) Clinical stage1-3 disease. (iii) R0 resection is acieved by gastrectomy with D1+ or D2 lymphadenectomy.

Exclusion criteria

Exclusion criteria: (i) Patients received any treatment before surgery. (ii) Clinical Stage 4 disease.

Design outcomes

Primary

Measure	Time frame
the ratio of the number of the harvested lymph nodes per time (minute)	—

Secondary

Measure	Time frame
the number of harvested lymph nodes	—

Countries

Japan

Outcome results